HBIO·416906105·US·equity·Healthcare - Medical Instruments & Supplies-Activist
HBIO (Harvard Bioscience, Inc.) is held by 38 institutional investors as of Q4 2025. Largest holders: VANGUARD GROUP INC ($1.3M), RENAISSANCE TECHNOLOGIES LLC ($683,006), TWO SIGMA INVESTMENTS, LP ($677,104). Net institutional sentiment: Bullish.
See how HBIO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer